Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

IBMs ExDividend Date and Implications for Shareholders

Elaine Mendonca by Elaine Mendonca
February 5, 2024
in Breaking News
0
Biotechnology Stock Market Today (1)
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

IBM‘s ex-dividend date, which falls on February 8, 2024, marks the crucial day by which shareholders must possess company shares to qualify for the upcoming dividend payment. To secure the dividend payout of $1.66 per share, investors must ensure ownership of IBM stocks prior to this date. Those who meet this requirement will receive the $1.66 dividend for each share they hold. The distribution of dividends to shareholders is scheduled for March 09, 2024. Following the ex-dividend date, it is anticipated that the stock price will undergo a downward adjustment of approximately $1.66 per share, reflecting the dividend amount.

IBM Stock Price Decreases by 1.28% on February 5, 2024: Market Confidence Remains Strong

On February 5, 2024, IBM’s stock price dropped by $2.37, resulting in a 1.28% decrease. The closing price on that day was $183.42, with an additional decrease of $0.02 in after-hours trading. Despite this drop, IBM’s position near the top of its 52-week range and above its 200-day simple moving average suggests strong performance and market confidence. It is important to consider the broader context and not view this drop as a reflection of IBM’s overall performance. Additionally, the after-hours trading decrease should be viewed with caution due to lower trading volume and liquidity. Investors should monitor IBM’s stock performance in the coming days and consider various factors before making any investment decisions based solely on this short-term price drop.

IBM Stock Performance on February 5, 2024: Steady Revenue, Impressive Net Income Growth

Title: IBM Stock Performance on February 5, 2024: Steady Revenue, Impressive Net Income Growth

Introduction

On February 5, 2024, IBM’s stock performance showcased steady revenue growth, while its net income experienced a remarkable surge. This article will analyze the financial data provided by CNN Money, highlighting IBM’s total revenue, net income, and earnings per share (EPS) for the past year and the fourth quarter.

Total Revenue

IBM’s total revenue for the past year stood at $61.86 billion, with the fourth quarter contributing $17.38 billion. Notably, the total revenue remained flat compared to the previous year and quarter.

Net Income

In terms of net income, IBM witnessed a significant increase of 357.44% since the previous year, reaching $7.50 billion. However, the net income remained flat at $3.29 billion in the fourth quarter.

Earnings per Share

IBM’s earnings per share (EPS) also exhibited impressive growth. With an EPS of $8.14 for the past year, the company experienced a remarkable increase of 353.08% compared to the previous year. In the fourth quarter, the EPS stood at $3.55, indicating a further increase of 92.43% since the previous quarter.

Analysis

IBM’s stock performance on February 5, 2024, demonstrated steady revenue figures, indicating the company’s ability to maintain its market position. However, investors might be looking for more substantial revenue growth to drive the stock’s performance in the future.

The significant surge in net income by 357.44% compared to the previous year is undoubtedly a positive indicator for IBM. It reflects the company’s successful cost management strategies and increased profitability. However, the flat net income in the fourth quarter suggests that IBM needs to focus on sustaining or further boosting its income growth to instill confidence in investors.

The impressive growth in earnings per share is another positive aspect of IBM’s stock performance on this date. The substantial increase of 353.08% in EPS compared to the previous year indicates that the company is generating more profit for each outstanding share. Moreover, the 92.43% increase in EPS since the previous quarter highlights IBM’s ability to maintain growth momentum.

Conclusion

On February 5, 2024, IBM’s stock performance showcased steady revenue figures, a remarkable increase in net income since the previous year, and impressive growth in earnings per share. While the total revenue remained flat, the substantial growth in net income and EPS suggests that IBM is on the right track to enhance profitability and attract investors.

However, the fourth-quarter figures indicate the need for sustained growth strategies to ensure continued success. Investors will be keen to observe future financial reports to assess whether IBM can maintain its positive trajectory.

Tags: IBM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Improvement in Market Sentiment for BWX Technologies BWXT

Biotechnology Stock Bull Market

Analyst expresses optimism and raises price target for TG Therapeutics NASDAQTGTX

Finance_Fiscal (2)

Anticipating Market Response to Jack Henry Associates Quarterly Earnings Report

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com